hrs-9190

Small moleculeexperimental

Clinical trial activity

3 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Apr 23, 2025 (NCT06932315)

Timeline

2020s

  1. Jan 1, 2025

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07252921Phase 2Oct 30, 2025Hengrui Therapeutics, Inc.
NCT07142850Phase 1Aug 26, 2025Hengrui Therapeutics, Inc.
NCT06932315Phase 1Apr 23, 2025Hengrui Therapeutics, Inc.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hengrui Therapeutics, Inc.For profit3322025
1 organizations
Page 1 / 1